Spectrum Library

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Publication Date January 2016

Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis Optica.

Publication Date February 2016

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.

Publication Date March 2016

Rapid exacerbation of neuromyelitis optica after rituximab treatment.

Publication Date April 2016

Rescue effects of intravenous immunoglobulin on optic nerve degeneration in a rat model of neuromyelitis optica.

Publication Date June 2016

Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.

Publication Date January 2016

Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica.

Publication Date November 2015

Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.

Publication Date May 2016

The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.

Publication Date March 2016

Gut microbiome analysis in neuromyelitis optica reveals over-abundance of Clostridium perfringens.

Publication Date July 2016

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination

Publication Date February 2016

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord

Publication Date March 2016

Previous
1
…
13
14
15
16
17
…
78
Next

Launch Dashboard